-
Mashup Score: 0Perna set to retire from Warp Speed later this summer - STAT - 4 year(s) ago
Gus Perna, the four-star army general responsible for coordinating the U.S. coronavirus vaccine response, is set to retire this summer.
Source: STATCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 2
Vin Gupta joined the tech giant early last year with plans to help steer Amazon Care. Just weeks into the job, the Covid-19 pandemic hit.
Source: STATCategories: Future of Medicine, Latest HeadlinesTweet-
The unlikely force behind Amazon's health care push: @VinGuptaMD is trying to be outspoken in public health, while also shepherding the ambitions of a highly secretive company. Great profile from @erbrod: via @statnews: https://t.co/coSAra6fef via @statnews
-
-
Mashup Score: 2SPACs are all the rage, but what are they? STAT explains - STAT - 4 year(s) ago
SPACs have proliferated since last year, raising billions on the promise of win-win transactions for investors and entrepreneurs alike.
Source: STATCategories: Future of Medicine, Latest HeadlinesTweet-
Watch this! Great explainer on SPACs, their benefits, and how they can (and many will) backfire on investors from @damiangarde. via @statnews https://t.co/YwVPHkzAGH via @statnews https://t.co/8YMGkW5BRg
-
-
Mashup Score: 4
The merger of Datavant and Ciox Health is the latest sign of growth in a burgeoning third-party medical data market.
Source: STATCategories: Future of Medicine, Latest HeadlinesTweet-
"The way de-identified data is regulated — or rather, unregulated — by the federal health privacy law HIPAA can leave patient information uniquely vulnerable." ...especially when so many large entities can profit from it. via @statnews: https://t.co/ZfgDfYHNet via @statnews
-
-
Mashup Score: 10
The FDA considers a nine-year timeline to be a “conservative estimate” and a “starting point” for talks with Biogen, an official said.
Source: STATCategories: Healthcare Professionals, Latest HeadlinesTweet-
Biogen, FDA at odds over timing of confirmatory trial of Alzheimer’s drug By @adamfeuerstein w/ me assisting. https://t.co/NyjKQ3cavA
-
9 yrs seems a long time to wait for a confirmatory trial of a drug that may cost $10k-25K per patient/ per year. via @statnews: https://t.co/5wmAOVxe6D via @statnews
-
-
Mashup Score: 1FDA grants historic approval to Alzheimer’s drug from Biogen - 4 year(s) ago
The landmark decision has been eagerly awaited by millions but will be hotly contested by some experts doubt the drug’s effectiveness.
Source: STATCategories: Future of Medicine, Latest HeadlinesTweet-
BREAKING: FDA grants historic approval to Alzheimer’s drug designed to slow cognitive decline. BUT a lot of questions remain about its effectiveness. via @damiangarde and @adamfeuerstein: https://t.co/9pFvRDvcdF via @statnews
-
-
Mashup Score: 2
As health care providers large and small prepare for a transition from virtual to in-person care, Carbon Health is carefully hedging its bets.
Source: STATCategories: Future of Medicine, Latest HeadlinesTweet-
Scoop from @erbrod on Carbon Health dive into digital diabetes care: “The vision is to make care in the home as high-quality as what you’d get in a clinic.” via @statnews: https://t.co/TpwO2hLpDA via @statnews
-
-
Mashup Score: 6
As personnel moves go, Verily’s hiring of Amy Abernethy is about as big as it gets in digital health. She told us about her new gig.
Source: STATCategories: Future of Medicine, Latest HeadlinesTweet-
How might @verilylifesci take shape as a business? Amy Abernethy's hiring offers some clues. via @statnews https://t.co/7rjFCYsLcO via @statnews
-
-
Mashup Score: 3
To close what she calls the pharma-startup gap, an industry vet is launching PharmStars, a 10-week bootcamp for digital health executives.
Source: STATCategories: Future of Medicine, Latest HeadlinesTweet-
A bootcamp launches to help digital health startups understand the inner-workings of the drug industry. Thanks to @NaomiFried for sharing your ideas with me. via @statnews: https://t.co/RE0l5EgugB via @statnews
-
-
Mashup Score: 4
Our latest eBook examines the promise and peril of Artificial Intelligence, as well as insights from experts in the field. Learn more.
Source: STATCategories: Future of Medicine, Latest HeadlinesTweet-
RT @kdpsinghlab: .@statnews recently produced a report on the promise and peril of AI in healthcare (link: https://t.co/UKD8lvGe1h) funded…
-
5 pm Friday Scoop from @nickflorko: Perna set to retire from Warp Speed later this summer via @statnews: https://t.co/POvBH9C3ld via @statnews